Rankings
▼
Calendar
DYN FY 2015 Earnings — Dyne Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena
DYN
Dyne Therapeutics, Inc.
$3B
FY 2015 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$842M
-42.6% YoY
Gross Profit
-$1.2B
-140.9% margin
Operating Income
$64M
7.6% margin
Net Income
$50M
5.9% margin
EPS (Diluted)
$0.40
Cash Flow
Operating Cash Flow
$94M
Free Cash Flow
-$181M
Stock-Based Comp.
$0
Balance Sheet
Total Assets
$11.5B
Total Liabilities
$8.6B
Stockholders' Equity
$2.9B
Cash & Equivalents
$505M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$842M
$1.5B
-42.6%
Gross Profit
-$1.2B
$321M
-469.5%
Operating Income
$64M
-$318M
+120.1%
Net Income
$50M
-$67M
+174.6%
← FY 2014
All Quarters
Q1 2015 →